Skip to content
OpenCapital
Get started

ADMA Biologics ADMA Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$5.87M+26.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$2.12M+8.1%
Zymeworks logo
ZymeworksZYME
$3.28M+0.6%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$36.2M-12.3%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$3.14M-21.1%
Quest Diagnostics logo
Quest DiagnosticsDGX
$174M+0.6%

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S4×-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's operating lease liabilities (current)?
ADMA Biologics (ADMA) reported operating lease liabilities (current) of $1.18M in Q1 2026.
How has ADMA Biologics's operating lease liabilities (current) changed year-over-year?
ADMA Biologics's operating lease liabilities (current) decreased by 1.0% year-over-year, from $1.19M to $1.18M.
What is the long-term trend for ADMA Biologics's operating lease liabilities (current)?
Over 5 years (2020 to 2025), ADMA Biologics's operating lease liabilities (current) has grown at a 24.5% compound annual growth rate (CAGR), from $365.68K to $1.1M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.